Charles River Laboratories International (CRL) Depreciation and Depletion (2011 - 2025)

Charles River Laboratories International (CRL) has reported Depreciation and Depletion for 15 consecutive years, with $45.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Depreciation and Depletion fell 6.82% year-over-year to $45.1 million; the TTM figure through Dec 2025 stood at $177.6 million (down 6.62% YoY), while the FY2025 annual figure was $177.6 million, down 6.62% from the prior year.
• Depreciation and Depletion came in at $45.1 million for Q4 2025 at Charles River Laboratories International, up from $44.8 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $155.6 million in Q4 2022, with the low at $559000.0 in Q1 2022.
• Average Depreciation and Depletion over 5 years is $42.1 million, with a median of $44.4 million recorded in 2023.
• The largest YoY upside for Depreciation and Depletion was 7878.53% in 2023 against a maximum downside of 70.12% in 2023.
• Year by year, Depreciation and Depletion stood at $138.6 million in 2021, then increased by 12.28% to $155.6 million in 2022, then tumbled by 70.12% to $46.5 million in 2023, then climbed by 4.09% to $48.4 million in 2024, then slipped by 6.82% to $45.1 million in 2025.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $45.1 million, $44.8 million, and $44.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.